報價延遲最少15分鐘:2024/09/27 18:31 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
46.39 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.82/--
|
|
企業價值
2.84B
|
| 資產負債 |
|
每股賬面淨值
8.38
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
245.11M
|
|
每股收益
1.93
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/09/27 18:31 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States. |